Posaconazole treatment in hematology patients: a pilot study of therapeutic drug monitoring

Therapeutic Drug Monitoring
Marie-Rose B S CrombagYuma A Bijleveld

Abstract

Posaconazole is indicated for prophylaxis and salvage therapy of invasive fungal infections. Based on pharmacokinetic-pharmacodynamic data, minimum serum concentrations for each indication have been proposed, for example, for prophylaxis >0.5-0.7 mg/L and for primary therapy >1.0 mg/L. Several drugs and comorbidities have been identified to hinder reaching target concentrations. It is postulated that patients with interacting drugs or comorbidities should be monitored for posaconazole concentrations. Patients aged 18 years and above were included for retrospective analysis if at least 1 serum posaconazole concentration was measured in our hospital between June 2009 and May 2010. Serum posaconazole concentrations were measured using a validated liquid chromatographic method with tandem mass-spectrometric analytical method. Patient characteristics, underlying disease, comedication, comorbidities, and therapeutic drug monitoring (TDM) interventions were collected retrospectively, based on (electronic) medical records. Seventeen patients were included, from whom 42 samples for posaconazole measurement were collected. In total, 8 patients did not reach adequate posaconazole concentration. Sixty percent of patients using a proton pum...Continue Reading

References

Mar 15, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Denise GravelGary Garber
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshJohn R Perfect
Jan 26, 2007·The New England Journal of Medicine·Andrew J UllmannSimon Durrant
Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
Jun 5, 2007·Pharmacotherapy·Angela Sansone-ParsonsTim G Mant
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Oct 29, 2008·Antimicrobial Agents and Chemotherapy·David AndesOscar Marchetti
Nov 19, 2008·Antimicrobial Agents and Chemotherapy·Roger J M BrüggemannDavid M Burger
Feb 18, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan-Willem C AlffenaarDonald R A Uges
Mar 4, 2009·Expert Review of Anti-infective Therapy·Winter J SmithJohn R Perfect
Apr 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roger J M BrüggemannDavid M Burger
Aug 4, 2009·Journal of Clinical Pharmacy and Therapeutics·A MotonZ Wang
Sep 16, 2009·Antimicrobial Agents and Chemotherapy·David LebeauxOlivier Lortholary

❮ Previous
Next ❯

Citations

Sep 1, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hyojin ChaeDong-Gun Lee
Nov 14, 2015·Therapeutic Drug Monitoring·Kim C M van der ElstJan-Willem C Alffenaar
Sep 25, 2016·Revista iberoamericana de micología·Diego H CáceresTonny W Naranjo
Sep 10, 2014·Antimicrobial Agents and Chemotherapy·Michael J DoltonAndrew J McLachlan
Nov 12, 2021·Expert Opinion on Pharmacotherapy·Paraskevi Panagopoulou, Emmanuel Roilides

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.